Lothar H. Finke is Head-Clinical Development & General Manager-Japan at Incyte Corp.

In the past Dr. Finke held the position of Chief Medical Officer at Argos Therapeutics, Inc., Principal at Merck KGaA Principal at Lexigen Pharmaceuticals Corp. and Principal at EMD Pharmaceuticals, Inc. (both are subsidiaries of Merck KGaA) and Principal at Basel Institute for Immunology.

He received a doctorate from Philipps University of Marburg.